Everest Organics Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 524790

₹236.00

Oct. 5, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #114 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Everest Organics Ltd. (this stock)	229	39.2	5.4%	-18.5%	—	36	39	28

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹279 Cr

EV / EBITDA

13.4x

EV / Sales

1.46x

Market cap / Sales

1.20x

Earnings yield

2.55%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 49 Cr, down 10.1% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 1 Cr, down 20.8% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	48	2	1	₹1.1500
March 31, 2026	49	2	—	₹2.6900
Dec. 31, 2025	43	1	0	₹0.9900
Sept. 30, 2025	51	3	1	₹1.1900
June 30, 2025	54	2	1	₹1.4500
March 31, 2025	41	1	—	₹1.3500
Dec. 31, 2024	42	1	1	₹1.4200
Sept. 30, 2024	44	1	1	₹0.9300
June 30, 2024	32	-6	-6	₹-7.6100
March 31, 2024	53	0	0	₹0.0700
Dec. 31, 2023	53	0	0	₹0.0200
Sept. 30, 2023	49	0	0	₹0.0400
June 30, 2023	43	0	0	₹0.0400

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	49	49	43	51	54	41	42	44	33	53	53	50	43
Operating revenue	48	49	43	51	54	41	42	44	32	53	53	49	43
Other income	0	0	0	0	1	0	0	0	0	0	0	0	0
Operating expenses	44	42	39	46	49	37	38	41	36	50	50	47	40
Operating profit	4	7	4	5	4	3	4	3	-4	3	3	3	3
Operating profit margin	8.9%	13.7%	8.3%	10.1%	8.2%	8.4%	9.6%	7.8%	-11.3%	5.6%	5.3%	5.5%	5.9%
Depreciation	2	2	2	2	2	2	1	1	1	2	1	1	1
Interest	2	3	1	1	1	1	1	1	1	1	1	1	1
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	2	2	1	3	2	1	1	1	-6	0	0	0	0
Tax	0	-0	1	2	1	-2	0	0	0	0	0	0	0
Net profit	1	—	0	1	1	—	1	1	-6	0	0	0	0
EPS	1.15	2.69	0.99	1.19	1.45	1.35	1.42	0.93	-7.61	0.07	0.02	0.04	0.04
Net profit (TTM)	—	—	—	—	—	—	-4	-5	-6	0	—	—	—
EPS (TTM)	6.02	6.32	4.98	5.41	5.15	-3.91	-5.19	-6.59	-7.48	0.17	0.24	2.12	3.25

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	1.3%	1.6%	197^†	160^†	198^†	190^†	202^†	183^†	156^†	113^†	108^†
Operating revenue	2.3%	1.6%	196^†	159^†	197^†	183^†	200^†	182^†	156^†	112^†	107^†
Other income	—	—	1^†	1^†	1^†	7^†	2^†	1^†	1^†	1^†	1^†
Operating expenses	—	—	176^†	152^†	186^†	182^†	194^†	159^†	138^†	—	99^†
Operating profit	177.2%	-2.8%	20^†	7^†	11^†	1^†	6^†	23^†	18^†	—	8^†
Operating profit margin	—	—	10.1%^†	4.5%^†	5.6%^†	0.5%^†	3.2%^†	12.6%^†	11.4%^†	—	7.4%^†
Depreciation	—	—	6^†	6^†	6^†	4^†	4^†	3^†	3^†	—	2^†
Interest	—	—	7^†	5^†	5^†	3^†	3^†	3^†	3^†	3^†	3^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	1^†	0^†
Profit before tax	345.5%	-14.2%	8^†	-3^†	1^†	0^†	2^†	17^†	12^†	3^†	1^†
Tax	—	—	2^†	-2^†	0^†	0^†	1^†	4^†	5^†	1^†	0^†
Net profit	—	—	—	—	0^†	—	1^†	14^†	8^†	3^†	—
EPS	—	-18.1%	6.32^†	-3.91^†	0.17^†	-0.23^†	1.43^†	17.14^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Operating margin	10.1%^†	4.5%^†	5.6%^†	0.5%^†	3.2%^†	12.6%^†	11.4%^†	—	7.4%^†
EBIT margin	7.4%^†	1.2%^†	3.1%^†	1.9%^†	2.4%^†	11.3%^†	10.0%^†	5.3%^†	3.9%^†
PBT margin	4.1%^†	-2.0%^†	0.3%^†	0.0%^†	0.9%^†	9.5%^†	7.9%^†	2.9%^†	1.3%^†
Net margin	—	—	0.1%^†	—	0.6%^†	7.6%^†	4.8%^†	2.3%^†	—
Interest coverage	2.23x^†	0.38x^†	1.11x^†	1.03x^†	1.56x^†	6.30x^†	4.84x^†	2.18x^†	1.52x^†
Dividend payout	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—
Current ratio	1.10x	1.06x	—	—	—	—	—	—	—
Quick ratio	0.81x	0.73x	—	—	—	—	—	—	—
Debt to equity	0.66x	0.68x	—	—	—	—	—	—	—
Return on equity	—	—	—	—	—	—	—	—	—
Return on assets	—	—	—	—	—	—	—	—	—
Return on capital employed	20.5%^†	2.3%^†	—	—	—	—	—	—	—
Asset turnover	0.88x^†	0.71x^†	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	4	-2	-8	-1	5
March 31, 2025	-5	-5	16	4	-9

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	223	75	66	43	7	167	152	0	44	45
March 31, 2025	224	70	60	39	9	148	140	6	48	45

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.